Sir, We note with interest the response from Mattman et al. . We agree that serum IgG subclass measurement is known to be associated with potential analytical errors as described. The methodology for serial IgG subclass measurement in this case was the binding site assays for the Siemens BNII™ nephelometer (latex enhanced for IgG3 and IgG4). The settings were changed between 2014 and 2015 to correct for antigen excess errors. We also agree that patients historically assessed as unlikely to have the disease, based solely on a low or normal serum IgG4 concentration, should be reassessed. Our previous work, however , has demonstrated, using double staining immunohistochemistry, that in patients with IgG4-related orbital disease there is a real elevation of tissue IgG2 plasma cells, distinct from tissue IgG4. It is still our belief, therefore, that the role of both serum and tissue IgG2 in the context of IgG4-RD may not be solely the result of analytical error and assay cross-reactivity. It is a phenomenon that requires further exploration and explanation. Funding: No specific funding was received from any bodies in the public, commercial or not-for-profit sectors to carry out the work described in this manuscript. Disclosure statement: The authors have declared no conflicts of interest. References 1 Mattman A , Chen LYC , van der Gugten G et al. Comment on: IgG4-related disease presenting with raised serum IgG2—real timeline of IgG4-RD? Rheumatology 2018 ; 57 : 1125 – 6 . 2 Chan ASY , Mudhar H , Shen SY et al. Serum IgG2 and tissue IgG2 plasma cell elevation in orbital IgG4-related disease: potential use in IgG4-RD assessment . Br J Ophthal 2017 ; 101 : 1576 – 82 . Google Scholar CrossRef Search ADS © The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: email@example.com This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/about_us/legal/notices)
Rheumatology – Oxford University Press
Published: Mar 23, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera